Limitations, agreements, and source contact

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) · Source last updated 2025-08-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

OTHER

restrictive Agreement

true

point Of Contact

email

clinical@palleonpharma.com

organization

Palleon Pharmaceuticals

phone

857-285-5900

title

Palleon Clinical Development

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice